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Pulmonary edema, a major complication of lung injury and inflammation, is defined 
as accumulation of extravascular fluid in the lungs leading to impaired diffusion of 
respiratory gases. Lung fluid balance across the alveolar epithelial barrier protects the 
distal airspace from excess fluid accumulation and is mainly regulated by active sodium 
transport and Cl− absorption. Increased hydrostatic pressure as seen in cardiogenic 
edema or increased vascular permeability as present in inflammatory lung diseases 
such as the acute respiratory distress syndrome (ARDS) causes a reversal of transep-
ithelial fluid transport resulting in the formation of pulmonary edema. The basolateral 
expressed Na+-K+-2Cl− cotransporter 1 (NKCC1) and the apical Cl− channel cystic 
fibrosis transmembrane conductance regulator (CFTR) are considered to be critically 
involved in the pathogenesis of pulmonary edema and have also been implicated in the 
inflammatory response in ARDS. Expression and function of both NKCC1 and CFTR can 
be modulated by released cytokines; however, the relevance of this modulation in the 
context of ARDS and pulmonary edema is so far unclear. Here, we review the existing 
literature on the regulation of NKCC1 and CFTR by cytokines, and—based on the known 
involvement of NKCC1 and CFTR in lung edema and inflammation—speculate on the 
role of cytokine-dependent NKCC1/CFTR regulation for the pathogenesis and potential 
treatment of pulmonary inflammation and edema formation.
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inTRODUCTiOn
Pulmonary edema, defined as excessive fluid accumulation in the interstitial and air spaces of the 
lungs, is a life-threatening condition leading to impaired gas exchange and respiratory failure. 
Depending on the underlying cause, pulmonary edema is distinguished into two types; hydrostatic 
and permeability-type edema. The most common form of hydrostatic edema is cardiogenic edema 
which occurs as major complication of left-sided heart failure and is characterized by increased 
transcapillary hydrostatic pressure gradients between pulmonary vasculature and interstitial space 
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resulting in interstitial lung edema and flooding of the alveoli 
with protein-poor fluid. Permeability-type lung edema, also 
referred to as non-cardiogenic pulmonary edema, is defined by 
an exudation of protein-rich fluid into the alveoli and develops 
characteristically in the process of inflammatory lung diseases 
such as the acute respiratory distress syndrome (ARDS) (1, 2). 
Two processes are critical for the accumulation of protein-rich 
fluid in the alveolar space: (1) the disruption of endothelial and 
epithelial barriers leading to increased vascular permeability 
and (2) the dysregulated expression or impaired function of ion 
channels in alveolar epithelial cells limiting fluid removal from 
the distal airspaces. As such, repair of the epithelial cell barrier 
and effective clearance of fluid from air spaces are essential pre-
requisites for resolution of pulmonary edema.
Several transporters (specified in the Section “Fluid 
Transport of Alveolar Epithelium”), expressed on alveolar type I 
(ATI) and type II (ATII) cells, are involved in active transport of 
salt and water through the epithelial barrier leading to alveolar 
fluid clearance (AFC). AFC is impaired in more than 80% of 
ARDS patients and associated with increased morbidity and 
mortality (3). Therefore, manipulation of alveolar fluid trans-
port could represent a suitable therapeutically target. However, 
molecular mechanism resulting in impaired epithelial fluid 
transport remains unclear. Inflammatory responses involv-
ing upregulation of pro-inflammatory cytokines including 
interleukin-1β (IL-1β), IL-8, tumor necrosis factor-α (TNF-α), 
and transforming growth factor-β (TGF-β) and their accumula-
tion in BALF and edema fluid are a critical hallmark of ARDS 
(4–7). In addition to their role in immune responses, these pro-
inflammatory mediators are considered to inhibit alveolar fluid 
transport by regulation of sodium and chloride transporter 
(7). However, present understandings of mechanisms by which 
cytokines regulate ion transport are far from complete, with 
previous work having focused on the regulation of Na+ trans-
port via epithelial Na+ channel (ENaC) and the Na+/K+-ATPase. 
In this review, we propose that cytokine-dependent regulation 
of Na+-K+-2Cl− cotransporter 1 (NKCC1) and Cl− channel 
cystic fibrosis transmembrane conductance regulator (CFTR) 
may play a critical role in lung edema formation and pulmonary 
inflammation. To this end, we first outline the general princi-
ples of alveolar fluid transport and the role of inflammatory 
cytokines in lung edema formation, then focus specifically on 
the role of NKCC1 and CFTR in pulmonary edema and inflam-
mation, and their regulation by cytokines, and finally conclude 
by proposing a critical role for cytokine-dependent regulation 
of NKCC1 and CFTR as a novel concept in the pathogenesis of 
pulmonary edema.
ReGULATiOn OF ACTive SALT AnD 
wATeR TRAnSPORT AnD eDeMA 
FORMATiOn
Fluid Transport of Alveolar epithelium
The alveolar epithelium forms a tight barrier between vasculature 
and air-filled compartment to control movement of protein and 
fluid under physiological conditions. It comprises ATI cells, which 
are responsible for gas exchange across the alveolo-capillary 
barrier, and ATII cells that fulfill several functions, most notably 
production and release of surfactant (8).
In the intact lung, AFC constantly moves fluid from the alveo-
lar space across the epithelial barrier into the interstitial space. 
Na+ is actively absorbed on the apical side of alveolar epithelial 
cells, which is mediated by several sodium channels (Figure 1), 
most notably the amiloride-sensitive ENaC (9), the sodium glu-
cose transporter (SGLT) (10, 11) and the sodium-coupled neutral 
amino acid transporter (SNAT) (12–14). On the basolateral 
surface, Na+ extrusion to the interstitial space is driven through 
the Na+-K+-ATPase (8) and the Na+/H+ antiporter (15). For 
electroneutrality and osmotic balance, Cl− and water follow the 
electrochemical gradient partly paracellularly and partly through 
aquaporins (specifically aquaporin 5) (16) and chloride channels, 
predominantly CFTR (17). Although it was thought that chan-
nels and transporter are primarily expressed in ATII cells, recent 
data demonstrated that ATI cells contain ENaC, CFTR, and the 
Na+-K+-ATPase suggesting a role for ATI cells in alveolar fluid 
transport (9, 18).
In response to lung injury and inflammation, the epithelial 
barrier becomes disrupted leading to increased influx of protein-
rich fluid and formation of pulmonary edema (Figure  1). 
Furthermore, the physiological protection provided by active 
salt and water transport is attenuated, resulting in impaired AFC 
in patients with both cardiogenic (19) and permeability-type (3) 
lung edema. On top of that, AFC may reverse into active alveolar 
fluid secretion (AFS), thus promoting rather than resolving 
edema formation. Recently, work from our group identified 
basolateral NKCC1 and apical-expressed CFTR as critical for 
the reversal of an absorptive into a secretory alveolar epithelium 
by driving Cl− secretion (20). Specifically, we could show that an 
acute increase in left atrial pressure decreases amiloride-sensitive 
Na+ uptake across the alveolar epithelium and concomitantly 
stimulates Na+ and Cl− uptake via basolateral NKCC1 and Cl− 
secretion into the alveolar space via apical CFTR, thus effectively 
reversing Na+-driven AFC into Cl− driven AFS. Importantly, 
inhibition of CFTR and NKCC1 improved AFC and attenuated 
edema formation. In line with this concept, previous studies 
have reported similar beneficial effects of NKCC inhibition 
on edema formation in different organs in that bumetanide 
reduced cerebral edema formation in response to ischemia (21) 
and furosemide improved fluid balance and reduced pulmonary 
edema in ARDS patients (22). Although these effects have tradi-
tionally been attributed to diuretic effects of non-specific NKCC 
inhibitors, improvement of respiratory function by furosemide 
in lung edema precedes the onset of diuresis (23, 24), suggesting 
alternative mechanisms such as NKCC/CFTR-mediated AFS in 
edema formation.
Pro-inflammatory Cytokines in Lung 
edema Formation
During early stages of injury, the lung is the site of acute inflam-
matory processes with excessive transepithelial neutrophil migra-
tion and continuous release and activation of pro-inflammatory 
mediators. Pro-inflammatory cytokines, produced by circulating 
FiGURe 1 | (A) Schematic model of the normal alveolus (left) and the injured alveolus (right) with edema formation in inflammatory lung disease. In pulmonary 
inflammation, the epithelial and endothelial barrier become disrupted leading to influx of protein-rich edema fluid and migration of neutrophils from the vasculature 
into the alveolar space. In the air space, alveolar macrophages secrete proinflammatory cytokines that stimulate chemotaxis and activate neutrophils which in turn 
produce and release further cytokines. (B) Distribution of epithelial ion transporter and proposed mechanism of alveolar fluid clearance (AFC) (left) and secretion 
(right). In alveolar type II and presumably also type I cells, AFC is mediated through apical Na+ entry by sodium channels like epithelial Na+ channel (ENac), 
sodium-coupled amino acid transporter (SNATs), and sodium glucose transporter (SGLT). Basolateral extrusion is driven by Na+-K+-ATPase and sodium hydrogen 
exchanger (NHE). Water and Cl− follow for electroneutrality. In pulmonary edema, ENaC and probably other sodium transporter are inhibited generating a gradient 
for Na+ influx via basolateral NKCC1. Cl− enters in cotransport with Na+, and exits along an electrochemical gradient on the apical side through CFTR, resulting in 
Cl−-driven fluid secretion and formation of lung edema.
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monocytes, alveolar macrophages, and neutrophils, promote 
recruitment and activation of additional immune cells and inflam-
matory molecules. A variety of cytokines and growth factors can 
be detected in BALF and edema fluid of ARDS patients including 
TNF-α, IL-1β, IL-8, and TGF-β1 (5, 6, 25, 26). These cytokines 
have been implicated to play a crucial role in the pathophysiology 
of pulmonary edema formation.
A critical involvement of TNF-α in edema formation has been 
documented in a series of experimental and clinical studies, which 
have previously been reviewed in detail (27). In brief, TNF-α 
reduces the expression of ENaC mRNA in alveolar epithelial cells 
and thereby decreases amiloride-sensitive sodium uptake (28). 
However, there is also evidence for a protective effect of TNF-α in 
pulmonary edema formation, as demonstrated by Borjesson and 
colleagues who identified in a rat model of intestinal ischemia-
reperfusion, a TNF-α-dependent stimulation of AFC in the early 
phase of injury (29). Similarly, a TNF-dependent and amiloride-
sensitive increase in alveolar fluid resorption was detected in a rat 
model of Pseudomonas aeruginosa pneumonia (30).
Inhibition of growth factor TGF-β1 protects wild-type mice 
from pulmonary edema in a bleomycin-induced lung injury 
model (31). An increased TGF-β1 activity in distal airways has 
been shown to promote edema by reducing alveolar epithelial 
sodium uptake and AFC. This effect of TGF-β1 is considered to be 
dependent on activation of the MAPK-ERK1/2 pathway resulting 
in decreased expression of ENaC mRNA (32). A similar effect 
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has been described for IL-1β, which was shown to reduce ENaC 
expression through p38–MAPK-dependent inhibition of ENaC 
promoter activity (33). In contrast, an in vitro study reported an 
IL-1β-mediated increase in epithelial repair induced by edema 
fluid (34).
The chemotactic mediator IL-8 promotes edema formation by 
blocking AFC (35). Accordingly, inhibition of IL-8 significantly 
diminishes edema caused by smoke inhalation, acid aspiration, or 
ischemia-reperfusion injury (36–38).
Overall, there is evidence that cytokines are important 
regulators of active ion transport and AFC. However, exact 
regulation of ion channels by inflammatory cytokines may 
be a complex phenomenon with functional effects depending 
on temporal and spatial profiles, interdependence between 
various cytokines, and the presence (in  vivo situation) or 
absence (in vitro assays) of immune cells. Detailed dissection 
of these scenarios poses a considerable challenge in terms 
of both resources and appropriate assays, yet would provide 
an invaluable platform for a better understanding of the 
complex crosstalk between inflammation and ion channel 
activity in a wide range of pulmonary and systemic inflam-
matory diseases.
CFTR AnD nKCC1 in inFLAMMATORY 
LUnG DiSeASe AnD PULMOnARY 
eDeMA
na+-K+-Cl− Cotransporter
The Na-K-Cl cotransporter (NKCC) mediates active electro-
neutral uptake of one Na+ and K+ with 2 Cl− molecules along 
an inwardly directed electrochemical gradient for Na+ and Cl−. 
Of the two known isoforms, NKCC1 and NKCC2, NKCC1 is 
found on the basolateral side on epithelial and endothelial cells in 
several organs, including the alveolar epithelium. In contrast, api-
cally expressed NKCC2 is only present in the kidney epithelium 
(39). Both isoforms are sensitive to loop diuretics like bumetanide 
and furosemide, which inhibit ion translocation (40).
To maintain cell shape and integrity during active salt and 
water secretion, activation of NKCC1 is strictly regulated. 
Activity of NKCC1 can be induced through hyperosmotic stress 
(41), low intracellular Na+ level, increase in intracellular cAMP, or 
changes in cell shape, and depends on direct phosphorylation by 
Ste20-related proline/alanine-rich kinase (SPAK) and oxidative 
stress responsive kinases (OSR1) (42).
Cystic Fibrosis Transmembrane 
Conductance Regulator (CFTR)
CFTR, which has been identified as the mutated gene in cystic 
fibrosis patients (43), is considered an atypical ATP-binding 
cassette (ABC) transporter which is activated by phosphoryla-
tion and ATP hydrolysis (44). It permits bidirectional transport 
of Cl− anion depending on the electrochemical gradient. CFTR 
is expressed on apical membranes of epithelial cells in distal 
airways and alveolar epithelium, where it mediates Cl− transport 
to maintain alveolar fluid homeostasis (45). CFTR expression 
and activation depends on intracellular cAMP or cGMP, which 
activate PKA and cGKII (46) leading to upregulation of CFTR 
expression and phosphorylation (47, 48).
expression of nKCC1 and CFTR in 
inflammatory Lung Diseases
NKCC1 and CFTR are both involved in a variety of biological 
processes ranging from ion transport to regulation of macrophage 
activation and modulation of cytokine production (49–52). Of 
relevance for this review, NKCC1 and CFTR have also been 
implicated in pulmonary inflammatory processes.
NKCC1 is upregulated in response to Gram-negative bacterial 
toxins like lipopolysaccharide (LPS) in the lung and kidney (53). 
Whether this enhanced NKCC1 gene expression is, however, 
mediated directly by LPS binding to its receptor inducing intra-
cellular signaling or via released inflammatory cytokines like 
TNF-α after LPS stimulation remains to be elucidated.
Nguyen and colleagues (54) proposed a role for NKCC1 in 
inflammatory processes in response to Klebsiella pneumoniae 
infection. Mice lacking NKCC1 were protected from bacteremia 
and lethal sepsis after infection and showed decreased vascular 
permeability. The number of migrated neutrophils in the air space 
was increased leading to a reduced number of K. pneumoniae in 
the lung of NKCC1-deficient mice. A potential mechanism that 
may explain the involvement of NKCC1 in edema formation and 
neutrophil transmigration was proposed by Matthay and Su (55), 
who speculated that expression of NKCC1 in endothelial and 
epithelial cells might be upregulated by inflammatory molecules 
in response to bacterial infections; however, this hypothesis still 
awaits functional validation, and regulatory pathways involved 
remain to be clarified. Along similar lines, a study by Andrade 
and colleagues reported upregulated NKCC1 expression along 
with downregulated ENaC in response to Leptospirosis infection, 
a model of sepsis leading to edema formation and ARDS (56). The 
authors proposed a regulation of transporter expression via JNK 
and NF-κB pathways during leptospirosis-induced pulmonary 
edema, yet exact signaling cascades remain unclear.
CFTR is considered an important modulator of inflam-
matory responses in the lung. Absence of a functional CFTR 
leads to chronic pulmonary inflammation, as seen in cystic 
fibrosis patients (57). In a murine model of cerebral and uterine 
Chlamydia trachomatis infection, CFTR mRNA and protein were 
shown to be upregulated causing increased tissue fluid accumula-
tion and edema formation (58). The authors hypothesized that 
increased CFTR expression and abnormal fluid accumulation 
upon C. trachomatis infection may depend on increased cytokine 
release. In pulmonary epithelial cells, CFTR functions as receptor 
for P. aeruginosa internalization leading to CFTR translocation 
into lipid rafts (59) and NF-κB mediated expression of IL-1β (60). 
However, the role of CFTR in lung injury and edema formation 
may be more complex. In a CF mouse model using CFTR-
deficient animals, Bruscia and colleagues (61) demonstrated 
an enhanced pulmonary inflammatory response with elevated 
cytokine levels in response to chronic LPS exposure. Similarly, Su 
and coworkers (51) reported aggravated inflammatory cytokine 
release and edema formation following LPS challenge in mice 
bearing the human functional CFTR mutation, F508del-CF, 
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or in mice treated with a pharmacological CFTR inhibitor. 
Importantly, subsequent chimeric experiments in wild-type mice 
reconstituted with F508del neutrophils or bone marrow, respec-
tively, revealed that pro-inflammatory, pro-edematous effect of 
functional CF inhibition was attributable to the lack of CFTR on 
immune cells, specifically neutrophils, rather than epithelial or 
other parenchymal cells (51). Hence, CFTR may promote both 
pro-and anti-edematous effects in inflammatory lung disease 
depending on its site of expression.
Taken together, functional concepts involving NKCC1 and 
CFTR in fluid transport and edema formation (Figure  1A) in 
combination with data demonstrating differential regulation of 
NKCC1 and CFTR in lung injury that coincides with edema 
formation point toward a critical role for CFTR and NKCC1 
in infection-induced pulmonary edema. While molecular 
mechanisms underlying the regulation of NKCC1 and CFTR by 
infectious pathogens remain to be elucidated, it is tempting to 
speculate on a critical role for inflammatory cytokines as putative 
mediators in the regulation of these channels. As discussed in the 
following section, multifunctional cytokines like TNF-α, IL-1β, 
and IL-8 are particularly attractive candidates as key regulators 
of NKCC1 and CFTR.
Regulation of nKCC1 and CFTR by 
Cytokines
Various signaling pathways have been suggested to play a role in 
NKCC1 activation and expression including WNK, MAP kinase/
ERK, p38, and JNK pathways (62–64). Notably, these pathways 
are also known to be stimulated by cytokines and growth factors 
like TNF-α and TGF-β, which activate intracellular p38 and JNK 
pathways (65, 66). In pulmonary inflammation, cytokines may 
bind to receptors on alveolar epithelial cells and induce intra-
cellular pathways resulting in activation of NKCC1, yet, direct 
evidence for such an effect in the intact, inflamed lung is pres-
ently outstanding. Consistent with this notion, however, NKCC1 
mRNA and protein levels were found to be selectively upregulated 
by TNF-α and IL-1β in endothelial and epithelial cells (53, 67). 
Conversely, inhibition of TNF-α and IL-1β by hypertonicity was 
found to be beneficial in cerebral edema, and the functional role 
of TNF-α and IL-1β in the regulation of NKCC1 expression was 
validated in vitro, leading the authors to propose that TNF-α and 
IL-1β may directly upregulate NKCC1 expression via JNK- and 
p38-dependent pathways (67).
For CFTR, the interplay between inflammatory cytokines and 
channel expression/activity is even more complex. As such, IL-8 
has been shown to indirectly regulate activity and biosynthesis 
of CFTR through inhibition of the β2-adrenergic receptor (AR) 
pathway (35) and subsequent phosphorylation of CFTR via 
cAMP-mediated PKA activation, which is considered to be 
essential for AFC (68). Downregulation of β2-AR in ATII cells 
by IL-8 blocked fluid transport across the alveolar epithelium 
via inhibition of CFTR phosphorylation and expression (35). 
Likewise, TGF-β has been proposed to diminish cAMP-driven 
chloride transport in colonic epithelia via inhibition of CFTR 
mRNA expression and protein synthesis (69). In 2007, Lee and 
colleagues (7) investigated the effect of edema fluid on transporter 
expression in alveolar epithelial cells and showed that cytokine-
containing edema fluid decreases expression and activation of 
CFTR leading to decreased AFC. However, incubation with indi-
vidual cytokines alone did not alter CFTR expression, suggesting 
a complex regulatory mechanism.
Other studies, reported an upregulation of CFTR mRNA and 
protein by IL-1β (70–72). The NF-κB-pathway has been identi-
fied to be involved in the IL-1β-dependent increase in CFTR 
expression (70). In agreement with this effect, CTFR-dependent 
AFS has been shown to be stimulated by IL-1β and TNF-α in 
airway submucosal glands via cAMP-dependent activation of 
PKA (73).
Contradictions in CFTR regulatory processes and its involve-
ment in fluid transport and edema formation may result from 
differences in expressed transport system in various cell types, 
and such heterogeneity may also be present in the pulmonary 
epithelium. Recently, it has been proposed that the distal airways 
might be comprised of secreting areas, located in the contra-
luminal regions of the pleats, and absorbing areas in the folds 
(74). Secretion and absorption of fluid is considered to occur 
simultaneously and independently maintaining the required level 
of airway surface liquid. Regulation of transporter expression may 
also vary in these areas. NKCC1 has been found to be abundantly 
expressed in the pleats of distal airways and less in the folds (75). 
No change in CFTR expression was detected in different areas 
(75), which is not surprising assuming CFTR is involved in fluid 
secretion and absorption. In lung injury, impaired alveolar fluid 
transport might be triggered by cytokine-mediated differential 
expression of ion channels including NKCC1 and CFTR that may 
putatively result in an increased expression and/or activation of 
NKCC1 and CFTR in secretory epithelia and an inhibition of 
channels in absorptive areas (Figure 2). While largely speculative 
at this stage, this hypothetical concept of a spatially (and poten-
tially temporally) differential regulation of ion channels involved 
in fluid absorption and secretion by inflammatory cytokines 
highlights the need for expanded research in this fascinating 
field. An in-depth understanding of changes in ion and fluid flux 
and their regulation may provide for optimized targets for edema 
resolution in acute inflammatory lung disease.
COnCLUSiOn
Acute respiratory distress syndrome with edema formation is 
a serious complication in critically ill patients. Resolution of 
edema needs strategies to restore epithelial barrier function and 
improve AFC. Formation of pulmonary edema in inflammatory 
lung diseases is caused by the loss of endothelial and epithelial 
barrier and impaired fluid and ion transport across the alveolar 
epithelium. Pro-inflammatory cytokines like TNF-α, TGF-β1, 
and IL-1β, which are released and activated in the early phase 
of lung inflammation, may regulate expression and activity of 
ion channels involved in fluid transport including NKCC1 and 
CFTR. Regulation of NKCC1 and CFTR is, however, complex, 
with discrepant results potentially depending on time profile, cell 
type, and co-stimulation by different cytokines resulting in a dis-
tinct multi-dimensional response that favors AFS while impair-
ing AFC. Manipulation of expression and activity of NKCC1 and 
FiGURe 2 | (A) Proposed model of organization of small airways. In lung epithelium, independent groups of cells simultaneously secrete and absorb to maintain 
fluid homeostasis. Under normal conditions, cells located in the pleats secrete fluid (blue) and cells located around the folds concurrently absorb secreted fluid (red). 
In lung injury, fluid transport in absorptive areas may be blocked while fluid secretion stays intact or increases. (B) Simplified, hypothetical concept of differential 
cytokine-dependent regulation of ion transporter in absorptive (red) and secretory (blue) areas in inflammatory lung disease. In apsorptive areas, AFC is impaired 
presumably through cytokine-mediated inhibition of CFTR and epithelial Na+ channel (ENaC). Proinflammatory cytokines [tumor necrosis factor-α (TNF-α), 
transforming growth factor-β (TGF-β), interleukin1β (IL-1β)] bind to their receptor inducing intracellular signaling cascades of MAP-kinases, JNK, p38, which prevent 
expression of ENaC. IL-8 blocks CFTR expression and activation by inhibition of cAMP/PKA pathway. In secretory areas, fluid secretion is stimulated by cytokines. 
Receptor binding of IL-1β, TNF-α, and TGF-β induces intracellular signaling pathways leading to activation and expression of CFTR and NKCC1.
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CFTR might serve as therapeutic target in inflammatory lung 
diseases with edema formation.
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